Current Pharmaceutical Product Launches in Europe

////Current Pharmaceutical Product Launches in Europe

Current Pharmaceutical Product Launches in Europe

The European Pharmaceutical market had seen current product launches, here is an overview.

Bayer

Xarelto® (rivaroxaban)

  • a novel anticoagulant taken as one tablet
  • invented in Bayer’s Wuppertal laboratories in Germany, and is being jointly developed by Bayer HealthCare and Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Qlaira®

  • first oral contraceptive providing a body-identical estrogen

 

Abbott

RealTime Molecular Assay In Europe For Detection Of HPV Infection

  • The CE-marked assay can identify patients infected with specific viral genotypes known to pose the highest risk for progression to cervical cancer

 

Johnson & Johnson

PREZISTA® (darunavir)

  • a protease inhibitor, with low-dose ritonavir as part of combination therapy in treatment-naïve adults (those who have never taken HIV medication before)
  • developed by Tibotec Pharmaceuticals. Tibotec, a division of Janssen-Cilag, will commercialize the product in Europe, Russia, Switzerland and other countries. The marketing authorization holder for PREZISTA in Europe is Janssen-Cilag International NV.

Biologic Stelara™ (ustekinumab)

  • treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA (psoralen plus ultraviolet A light)
  • Centocor Ortho Biotech Inc. discovered STELARA and has exclusive marketing rights to the product in the United States. Janssen-Cilag companies have exclusive marketing rights in all countries outside of the United States

 

 

Topic: pharmaceutical market research in europe

 

Our Specialties

 

  • Multicountry Medical Research
  • Competitive Intelligence
  • ADHD
  • Allergy / Immunology
  • Anesthesiology
  • Asthma
  • Biotechnology
  • Cardiology
  • Chiropractic
  • CINV / PONV
  • Clinical Research
  • Consumer Healthcare Research
  • Contraceptives
  • Coronary Heart Disease
  • Dentistry
  • Dermatology
  • Depression
  • Diabetes
  • Dyslipidemia
  • eHealth
  • Electrophyiology
  • Emerging Medicine
  • Endocrinology
  • Endometriosis
  • Growth Hormone
  • Family Practice
  • Fungal Disorders
  • Gastroenterology
  • General practice
  • Geriatrics
  • Hepatitis
  • Hematology
  • HIV / AIDS
  • Homeopathy
  • Hospital Beds
  • Hypertension
  • Incontinence
  • Infectious Diseases
  • Infertility
  • Inflammatory Bowel Syndrome
  • Medical Equipment
  • Metabolic Syndrome
  • Neurology
  • Neuro Surgery
  • Nursing
  • Nutrition
  • Obstetrics /Gynecology
  • Off-patent Drug Market
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Osteoporosis
  • Over-the-counter Drug Market
  • Packaging / Image Testing
  • Pain Management
  • Pediatrics
  • Pharmacists
  • Physical Medicine and Rehabilitation
  • Physical Fitness
  • Plastic, Cosmetic and Reconstructive Surgery
  • Preventative Medicine
  • Prostate Cancer
  • Psychiatry
  • Radiology
  • Retail Drug Store
  • Rheumatology
  • Sexual Dysfunction
  • Urology
  • Wound care
2017-04-07T00:24:31+00:00